cysteine and Ewing Sarcoma

cysteine has been researched along with Ewing Sarcoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ban, J; Jug, G; Kovar, H; Pospísilová, S; Siligan, C	1
Bernstein, ML; Dubowy, RL; Fahey, RC; Newton, GL; Souid, AK	1

Trials

1 trial(s) available for cysteine and Ewing Sarcoma

Article	Year
WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study. Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:6 Topics: Adolescent; Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Bone Neoplasms; Child; Cyclophosphamide; Cysteine; Female; Humans; Ifosfamide; Infusions, Intravenous; Kinetics; Male; Mesna; Radiation-Protective Agents; Sarcoma, Ewing; Sulfhydryl Compounds; Time Factors	1999

Article

Year

WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study.

Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:6

Topics: Adolescent; Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Bone Neoplasms; Child; Cyclophosphamide; Cysteine; Female; Humans; Ifosfamide; Infusions, Intravenous; Kinetics; Male; Mesna; Radiation-Protective Agents; Sarcoma, Ewing; Sulfhydryl Compounds; Time Factors

1999

Other Studies

1 other study(ies) available for cysteine and Ewing Sarcoma

Article	Year
Constitutive and DNA damage inducible activation of pig3 and MDM2 genes by tumor-derived p53 mutant C277Y. Molecular cancer research : MCR, 2004, Volume: 2, Issue:5 Topics: Apoptosis; Base Sequence; Cell Line, Tumor; Cysteine; DNA Damage; Humans; Intracellular Signaling Peptides and Proteins; Mutation; Nuclear Proteins; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Sarcoma, Ewing; Tumor Suppressor Protein p53	2004

Article

Year

Constitutive and DNA damage inducible activation of pig3 and MDM2 genes by tumor-derived p53 mutant C277Y.

Molecular cancer research : MCR, 2004, Volume: 2, Issue:5

Topics: Apoptosis; Base Sequence; Cell Line, Tumor; Cysteine; DNA Damage; Humans; Intracellular Signaling Peptides and Proteins; Mutation; Nuclear Proteins; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Sarcoma, Ewing; Tumor Suppressor Protein p53

2004